Oluwaseun Olusegun Fatoba, PhD
Affiliations: | 2004-2009 | Human Anatomy | Ladoke Akintola University, Nigeria |
2011-2012 | Human Anatomy | University of Lagos, Nigeria | |
2013-2017 | Neuroimmunology | Ruhr-University Bochum/International Graduate School of Neuroscience | |
2018-2018 | Neuroimmunology | Ruhr-University Bochum, Bochum, Nordrhein-Westfalen, Germany | |
2019- | Molecular Neuroscience | Osaka University/Immunology Frontier Research Center |
Area:
Neurodegenerative diseasesGoogle:
"Oluwaseun Fatoba"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRalf Gold | grad student | 2013-2018 | Ruhr University–Bochum, Germany | |
(Gisa Ellrichmann as co-mentor) | ||||
Toshihide Yamashita | post-doc | 2019- | Osaka University |
Collaborators
Sign in to add collaboratorGal Bitan | collaborator | ||
Simon Ebbinghaus | collaborator | ||
kalliopi Pitarokoili | collaborator |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Abbaoui A, Fatoba O, Yamashita T. (2023) Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases. Frontiers in Cellular Neuroscience. 17: 1181071 |
Fatoba O, Itokazu T, Yamashita T. (2021) Complement cascade functions during brain development and neurodegeneration. The Febs Journal |
Fatoba O, Itokazu T, Yamashita T. (2020) Microglia as therapeutic target in central nervous system disorders. Journal of Pharmacological Sciences. 144: 102-118 |
Fatoba O, Ohtake Y, Itokazu T, et al. (2020) Immunotherapies in Huntington's disease and α-Synucleinopathies. Frontiers in Immunology. 11: 337 |
Ellrichmann G, Blusch A, Fatoba O, et al. (2019) Author Correction: Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 9: 4960 |
Fatoba O, Kloster E, Reick C, et al. (2018) Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease. Experimental Neurology |
Ellrichmann G, Blusch A, Fatoba O, et al. (2017) Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 7: 4947 |
Pitarokoili K, Kohle F, Motte J, et al. (2017) Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis. Journal of Neuroimmunology. 309: 58-67 |
Vöpel T, Bravo-Rodriguez K, Mittal S, et al. (2017) Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01. Journal of the American Chemical Society |
Fatoba O, Kloster E, Saft C, et al. (2016) L22 Intranasal application of NPY and NPY13–36 ameliorate disease pathology in R6/2 mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87 |